NORETHINDRONE Drug Patent Profile
✉ Email this page to a colleague
When do Norethindrone patents expire, and when can generic versions of Norethindrone launch?
Norethindrone is a drug marketed by Amneal Pharms, Glenmark Pharms Ltd, Lupin Ltd, Naari Pte Ltd, Novast Labs, Xiromed, Aurobindo Pharma Ltd, Barr, Barr Labs Inc, Dr Reddys Labs Sa, Mylan Labs Ltd, Apotex, Watson Labs, Watson Pharms Teva, Watson Labs Teva, and Teva Branded Pharm. and is included in sixty-three NDAs.
The generic ingredient in NORETHINDRONE is mestranol; norethindrone. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORETHINDRONE?
- What are the global sales for NORETHINDRONE?
- What is Average Wholesale Price for NORETHINDRONE?
Summary for NORETHINDRONE
![NORETHINDRONE drug patent expirations Drug patent expirations by year for NORETHINDRONE](/p/graph/s/t/NORETHINDRONE-patent-expirations.png)
![Drug Prices for NORETHINDRONE](/p/graph/drug-price/NORETHINDRONE.png)
See drug prices for NORETHINDRONE
![Drug Sales Revenue Trends for NORETHINDRONE](/p/graph/drug-sales-revenues/NORETHINDRONE.png)
Recent Clinical Trials for NORETHINDRONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bio Genuine (Shanghai) Biotech Co., Ltd. | Phase 3 |
University of Chicago | Phase 4 |
Myovant Sciences GmbH | Phase 4 |
Pharmacology for NORETHINDRONE
Drug Class | Progestin |